Literature DB >> 17558425

The contribution of immunology to the rational design of novel antibacterial vaccines.

Stefan H E Kaufmann1.   

Abstract

In most cases, a successful vaccine must induce an immune response that is better than the response invoked by natural infection. Vaccines are still unavailable for several bacterial infections and vaccines to prevent such infections will be best developed on the basis of our increasing insights into the immune response. Knowledge of the signals that determine the best possible acquired immune response against a given pathogen - comprising a profound T- and B-cell memory response as well as long-lived plasma cells - will provide the scientific framework for the rational design of novel antibacterial vaccines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558425     DOI: 10.1038/nrmicro1688

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  42 in total

1.  Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides.

Authors:  Katherina Siewert; Joachim Malotka; Naoto Kawakami; Hartmut Wekerle; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Nat Med       Date:  2012-05       Impact factor: 53.440

2.  Humoral and cellular immune responses to measles and tetanus: the importance of elapsed time since last exposure and the nature of the antigen.

Authors:  Patricia O Viana; Erika Ono; Maristela Miyamoto; Reinaldo Salomao; Beatriz T Costa-Carvalho; Lily Y Weckx; Maria Isabel de Moraes-Pinto
Journal:  J Clin Immunol       Date:  2010-04-20       Impact factor: 8.317

Review 3.  Bacterial outer membrane vesicles in disease and preventive medicine.

Authors:  Can M Unal; Viveka Schaar; Kristian Riesbeck
Journal:  Semin Immunopathol       Date:  2010-12-12       Impact factor: 9.623

4.  Anti-group A streptococcal vaccine epitope: structure, stability, and its ability to interact with HLA class II molecules.

Authors:  Luiza Guilherme; Martha P Alba; Frederico Moraes Ferreira; Sandra Emiko Oshiro; Fabio Higa; Manuel E Patarroyo; Jorge Kalil
Journal:  J Biol Chem       Date:  2010-12-17       Impact factor: 5.157

Review 5.  The biology and future prospects of antivirulence therapies.

Authors:  Lynette Cegelski; Garland R Marshall; Gary R Eldridge; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2008-01       Impact factor: 60.633

6.  An entirely cell-based system to generate single-chain antibodies against cell surface receptors.

Authors:  Barbara D Lipes; Yu-Hsun Chen; Hongzheng Ma; Herman F Staats; Daniel J Kenan; Michael Dee Gunn
Journal:  J Mol Biol       Date:  2008-04-07       Impact factor: 5.469

Review 7.  The role of B cells and humoral immunity in Mycobacterium tuberculosis infection.

Authors:  John Chan; Simren Mehta; Sushma Bharrhan; Yong Chen; Jacqueline M Achkar; Arturo Casadevall; JoAnne Flynn
Journal:  Semin Immunol       Date:  2014-10-28       Impact factor: 11.130

8.  Multivalent Antigens for Promoting B and T Cell Activation.

Authors:  Nitasha R Bennett; Daniel B Zwick; Adam H Courtney; Laura L Kiessling
Journal:  ACS Chem Biol       Date:  2015-06-02       Impact factor: 5.100

9.  Vaccine adjuvants alter TCR-based selection thresholds.

Authors:  Laurent Malherbe; Linda Mark; Nicolas Fazilleau; Louise J McHeyzer-Williams; Michael G McHeyzer-Williams
Journal:  Immunity       Date:  2008-05-01       Impact factor: 31.745

Review 10.  How B cells shape the immune response against Mycobacterium tuberculosis.

Authors:  Paul J Maglione; John Chan
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.